Eris Lifesciences Limited (BOM:540596)

Eris Lifesciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	29,352	28,793	19,913	16,618	13,262	11,926
Revenue Growth (YoY)	30.64%	44.59%	19.83%	25.31%	11.20%	12.71%
Cost of Revenue	7,373	7,332	3,964	3,613	2,640	2,419
Gross Profit	21,980	21,461	15,950	13,005	10,621	9,507
Selling, General & Admin	5,379	5,261	4,137	3,548	2,622	2,439
Other Operating Expenses	6,152	6,018	5,038	4,070	3,108	2,762
Operating Expenses	14,634	14,434	11,005	8,789	6,376	5,631
Operating Income	7,346	7,027	4,945	4,217	4,245	3,876
Interest Expense	-2,196	-2,313	-848	-261.68	-41.46	-18.02
Interest & Investment Income	50.6	50.6	70.1	22.99	60.98	22.85
Earnings From Equity Investments	9.5	0.6	-	-	-	-
Currency Exchange Gain (Loss)	0.9	0.9	18.6	-	-	-
Other Non Operating Income (Expenses)	102.6	92.1	55.7	17.22	15.19	14.46
EBT Excluding Unusual Items	5,314	4,858	4,241	3,995	4,280	3,895
Gain (Loss) on Sale of Investments	39.8	39.8	93.8	71.32	166.09	49.77
Gain (Loss) on Sale of Assets	-9.2	-9.2	-21.4	-20.05	-42.54	-0.18
Other Unusual Items	0.2	0.2	-	-	18.68	-
Pretax Income	5,345	4,889	4,313	4,046	4,422	3,945
Income Tax Expense	1,242	1,142	342.2	304.83	364.09	393.62
Earnings From Continuing Operations	4,102	3,747	3,971	3,742	4,058	3,551
Minority Interest in Earnings	-237	-228.3	-50.7	79.98	3.24	-
Net Income	3,865	3,518	3,921	3,822	4,061	3,551
Net Income to Common	3,865	3,518	3,921	3,822	4,061	3,551
Net Income Growth	1.64%	-10.26%	2.59%	-5.90%	14.36%	19.78%
Shares Outstanding (Basic)	136	136	136	136	136	136
Shares Outstanding (Diluted)	136	136	136	136	136	136
Shares Change (YoY)	0.05%	0.09%	-	0.19%	0.02%	-1.03%
EPS (Basic)	28.41	25.85	28.82	28.10	29.89	26.16
EPS (Diluted)	28.36	25.81	28.79	28.07	29.88	26.14
EPS Growth	1.56%	-10.35%	2.56%	-6.06%	14.31%	21.07%
Free Cash Flow	-	9,100	3,569	-5,497	2,572	3,496
Free Cash Flow Per Share	-	66.77	26.21	-40.37	18.93	25.73
Dividend Per Share	-	7.350	-	7.350	6.010	5.500
Dividend Growth	-	-	-	22.30%	9.27%	91.64%
Gross Margin	74.88%	74.53%	80.10%	78.26%	80.09%	79.72%
Operating Margin	25.03%	24.40%	24.83%	25.37%	32.01%	32.50%
Profit Margin	13.17%	12.22%	19.69%	23.00%	30.62%	29.78%
Free Cash Flow Margin	-	31.61%	17.92%	-33.08%	19.40%	29.31%
EBITDA	10,702	10,047	6,625	5,259	4,827	4,261
EBITDA Margin	36.46%	34.90%	33.27%	31.65%	36.40%	35.73%
D&A For EBITDA	3,356	3,021	1,681	1,043	582.18	384.9
EBIT	7,346	7,027	4,945	4,217	4,245	3,876
EBIT Margin	25.03%	24.40%	24.83%	25.37%	32.01%	32.50%
Effective Tax Rate	23.24%	23.36%	7.93%	7.53%	8.23%	9.98%
Revenue as Reported	29,663	29,120	20,330	16,963	13,731	12,206
Advertising Expenses	-	180.6	66.8	63.85	87.47	125.05

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.